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Abstract RT-PCR was undertaken on total RNA extracts from 
bone and scales of the rainbow trout, Oncovhynchus mykiss. The 
rainbow trout estrogen receptor (ER)-specific primers used 
amplified a single product of expected size from each tissue 
which, using Southern blotting, strongly hybridized with a 3 2 P -
labelled rtER probe under stringent conditions. These data 
provide the first in vivo evidence of ER mRNA in bone and scale 
tissues of rainbow trout and suggest that the effects of estrogen 
observed in this study (increased bone mineral and decreased 
scale mineral contents, respectively) may be mediated directly 
through ER. 
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1. Introduction 
The significantly elevated plasma 17P-estradiol levels de-
tected in female teleost fish during the reproductive period 
are associated with greatly enhanced hepatic vitellogenin 
(Vg) production, increased physiological demands for calcium 
and elevated plasma calcium concentrations [1,2]. Radiotracer 
studies have indicated that the calcium demand is met in part 
by a mobilization of calcium from internal stores, particularly 
the scales and also muscle [3-5], and by an increased uptake 
from the environment [5]. However, the mechanism(s) by 
which 17[5-estradiol exerts its effects on calcium mobilization 
in teleosts are unclear. 
Estrogen receptor (ER) m R N A has been identified in sev-
eral tissues of the rainbow trout, Oncorhynchus mykiss, includ-
ing the liver, forebrain, pituitary, pineal gland and retina [6-
8]. Sequencing of rainbow trout E R (rtER) c D N A has re-
vealed two domains ( D N A binding and steroid hormone 
binding) with strong homology to the human, avian and Xe-
nopus E R [6,9]. The major transcript (3.5 kilobases) detected 
in each tissue codes for a 65 k D a ER protein [9,10] which is 
similar in size to the human ER [11]. To date, however, the 
presence of ER m R N A has not been demonstrated in teleost 
mineralized tissues which, as in other vertebrates, are impor-
tant targets for estrogenic action. 
Evidence for the expression of ER in mammalian bone was 
presented relatively recently. High-affinity E R were shown to 
be expressed in primary human osteoblast-like cells and in 
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human and rat osteoblast-like cell lines [12,13]. While high-
lighting the relatively low expression of ER in bone cells com-
pared with other target tissues (e.g. the uterus), these studies 
provided clear evidence that the effects of 17(3-estradiol on 
bone could be mediated directly through a classical receptor 
mechanism. Recent work on ER-knockout transgenic mice, 
which lack functional ER and show significantly reduced 
bone mineral densities compared with wild-type controls, 
strongly supports a direct role for ER action in bone physi-
ology [14]. Other studies have described ER expression and 
estrogenic effects in a variety of osteoblast-like and osteoclast-
like cells derived from humans and animals (for a review, see 
[11,15]) and the presence of ER m R N A in vivo has also been 
reported in rat bone [16,17]. 
In the current study, ER m R N A expression in vivo is dem-
onstrated in bone and scale tissues of the rainbow trout using 
RT -PCR and 17P-estradiol is shown to have differential ef-
fects on calcium and phosphate mobilization in these tissues. 
2. Materials and methods 
2.1. Animals and estrogen treatment 
Juvenile rainbow trout (approximately 5 months old, weighing 
< 75 g) were obtained from local suppliers and maintained in aquaria 
in aerated, running fresh water. Fish, in weight-matched groups, were 
injected intraperitoneally with either 17p-estradiol dissolved in ethanol 
(25 ug/g body weight) or injection vehicle alone («=11, both groups). 
Fish were not fed immediately prior to and during the experimental 
period. Fourteen days after injection the fish were killed and bone, 
scales, muscle and liver were removed, rigorously cleaned of connec-
tive tissue, snap-frozen in liquid nitrogen and stored at — 70°C. 
2.2. RNA extraction 
Equivalent amounts of bone, scales and muscle were ground to a 
fine powder in the presence of liquid nitrogen using a mortar and 
pestle. Total RNA was then extracted from the powdered samples 
following the standard method of Chomczynski and Sacchi [18]. Total 
hepatic RNA was extracted using LiCl-urea as previously described 
[9,19]. Liver and muscle were used as positive and negative controls, 
respectively. 
2.3. Reverse transcription-PCR 
10 (_ig aliquots of total RNA extracts were reverse-transcribed into 
complementary DNA (cDNA) using 7 u,M random hexanucleotide 
primers and 1 U/ml AMV reverse transcriptase (Amersham, France). 
Samples were incubated for 1 h at 42°C in a 20 ul solution containing: 
50 mM Tris HC1 (pH 8.3), 50 mM KC1, 10 mM MgCl2, 1 U/ml 
human placental ribonuclease inhibitor and 1 mM each of dATP, 
dCTP, dGTP and dTTP. 
The primer sequences used for the PCR were: (1) 5'-ACATG-
TACCCTGAGGAGACA-3', commencing at nucleotide 222, and 
(2) 5'-TCAGTACCTCGTCTCGTTGGC-3', commencing at nucleo-
tide 645 of the rtER. The primers amplified a 423-base-pair fragment, 
spanning exons 2 and 3, coding for the A/B region of the rtER. 
Aliquots of cDNA (corresponding to 500 ng total RNA) were added 
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to a 100 ul reaction mixture containing: 1 X buffer (10 mM Tris-HCl, 
1.5 mM MgCl2, 50 mM KC1, pH 8.3), 0.2 mM each of dATP, dCTP, 
dGTP and dTTP, 0.05 U/ul Taq DNA polymerase (Boehringer 
Mannheim, France) and 1 uM of each primer. Using a Techne ther-
mocycler, PCR was initiated at 94°C for 1 min followed by 29 cycles 
of incubation at 94°C for 1 min, 52°C for 1 min and 72°C for 1 min, 
and a final incubation at 72°C for 10 min. RT-PCR was repeated 
4 times on samples from different fish. 
Agarose and denaturing gel electrophoresis along with Southern 
and Northern hybridizations were performed using standard methods 
[20-22]. Full-length rtER [9] and rtVg [23] cDNA probes were used 
for the hybridizations, the latter being used solely for liver Northern 
blots as a positive control. 
2.4. Mineral analyses 
Skin, containing the scales, was dissected from the body of the fish 
and analyzed separately from the skinned body. Organic matter was 
removed over 24 h at 60°C using 2 changes of 85% hydrazine hydrate 
[24], The remaining mineralized tissue was washed repeatedly in dis-
tilled water, sequentially dehydrated in ethanol and xylene and then 
dried. Tissues were subsequently ashed at 900°C prior to mineral 
analyses. Calcium contents were measured by atomic absorption spec-
troscopy while phosphate concentrations were measured colorimetri-
cally using an automatic analyzer. 
2.5. Statistical analysis 
The effect of estrogen treatment on calcified tissue mineral contents 
was assessed by analysis of variance and Bonferroni /-tests were used 
subsequently to allow for multiple comparisons. Value of P<0 .05 
was taken as significant. 
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3. Results and discussion 
RT-PCR has been used successfully to identify low-abun-
dance ER transcripts in rat bone [17]. In the current study, a 
single band of expected size ( ~ 420 base-pairs) was visible on 
agarose gel electrophoresis of PCR-amplified products from 
liver, bone and scale. Southern blot analysis of the PCR prod-
ucts revealed strong hybridization with a 32P-labeled rtER 
probe under stringent conditions (Fig. 1). This is the first 
report of ER mRNA expression in mineralized tissues of a 
teleost fish. The longer autoradiographic exposure time re-
quired to visualize the bone and scale hybridizations (48 h) 
compared with that for liver (24 h) suggests that ER expres-
sion in these tissues may be lower than in liver. A second 
primer pair, corresponding to the 5'-non-coding region of 
the rtER, was also used and again amplified a single band 
(~220 base pairs) from each tissue which hybridized with 
the rtER probe (not shown). No ER signal was detectable 
in muscle tissue which was used as a negative control. The 
detection of ER mRNA expression in bone and scale in vivo, 
while not proving that ER protein is present, strongly suggests 
that the effects of 17(3-estradiol on calcium mobilization (see 
Fig. 3) may be mediated directly through ER expressed in 
these tissues. 
Northern hybridization analysis of total RNA, with a full-
length 32P-labelled rtER probe, detected ER mRNA expres-
sion in liver which was upregulated following 17p-estradiol 
treatment, as has been previously described [23]. However, 
ER mRNA was not detectable by Northern analysis in 
muscle, bone or scale before or after 17(3-estradiol treatment. 
Preliminary immunohistochemical staining of sectioned bone 
and scale, using a specific rabbit anti-rtER antibody previ-
ously used to detect immunoreactive ER in the brain of rain-
bow trout [10], also did not detect the presence of rtER pro-
tein (not shown). These results are, perhaps, not altogether 
surprising. From the literature it is clear that ER expression 
Fig. 1. Southern blot analysis of RT-PCR products from liver, 
bone, scale and muscle. PCR products were run on a 2% agarose 
gel, transferred to a nylon membrane overnight and hybridised 
under stringent conditions [20] with a 32P-labelled rainbow trout ER 
probe. Autoradiography: liver, 24 h; bone and scale, 48 h; muscle, 
72 h. 
in mammalian bone is low compared with uterine tissue, 
which is a primary target for 17[3-estradiol action 
[12,13,15,25,26]. The results of the current study suggest that 
ER mRNA levels in rainbow trout bone and scale may be low 
compared with liver, the primary target tissue for 17p-estra-
diol in teleosts [23]. Consequently, ER message and protein 
may be difficult to detect in these calcified tissues using con-
ventional methods [26,27]. In contrast, vitellogenin mRNA 
expression in the liver (positive control) was greatly upregu-
lated by 17p-estradiol [23] having been undetectable before 
treatment (Fig. 2). 
Following 17P-estradiol treatment calcium and phosphate 
contents were significantly reduced ( P < 0.001, both cases) in 
scales and significantly increased (P<0.01, both cases) in 
bone (Fig. 3a,b). Previous studies on teleosts using radiola-
belled calcium have not shown significant increases in bone 
calcium content in response to estrogen [3-5]. However, the 
consensus of opinion from these studies and the current work 
is that 17P-estradiol does not stimulate loss of calcium from 
teleost bone. In this regard, 17P-estradiol may be considered 
to have a bone-preserving effect in teleosts analogous to its 
role in female mammals. The mechanisms of 17p-estradiol 
action in mammalian bone are not fully understood but ER 
have been detected in osteoblasts and osteoclasts [12,13,15,25] 
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Fig. 2. Upper panel: Northern blot analysis of total RNA from 
trout liver. Total RNA was extracted from livers of estrogen-treated 
and untreated trout, then 30 ug was separated on a denaturing 
formaldehyde-agarose gel, transferred to a nylon membrane over-
night and hybridised under stringent conditions [20] with a 32P-la-
belled rainbow trout vitellogenin (Vg) probe prior to autoradiogra-
phy for 4 h. Vg was significantly upregulated by estrogen. Lower 
panel: Methylene blue staining of ribosomal RNA shows uniform 
RNA loading of the gel. 
and 17(3-estradiol has been shown to affect both cell types 
[11]. The presence of osteoblasts and osteoclasts has also 
been reported in teleost bone [28-33] and these cells are con-
sidered to be similar to their mammalian counterparts. In 
addition, recent histomorphometric studies have shown that 
17p-estradiol decreases osteoclast-mediated resorption of tele-
ost bone (Persson, P., personal communication). It is prob-
able, therefore, that the osteoblasts and osteoclasts present in 
teleost bone express ER and are targets for the direct actions 
of 17p-estradiol. 
17P-Estradiol treatment causes a profound decrease in scale 
calcium content, but the mechanisms involved in this effect 
are unknown. Osteoblasts and osteoclasts have been identified 
in scales [31,32,34,35] and, as mentioned above, in mammals 
these cells are targets for the direct actions of 17|3-estradiol. 
The presence of ER mRNA in scales suggests that 17|3-estra-
diol may act directly through ER expressed by cells within the 
scale micro-environment. This is supported by the recent find-
ing that 17P-estradiol markedly and dose-dependently down-
regulated the mRNA expression of osteonectin, a collagen 
binding protein derived from osteoblasts in mammals, in a 
cell line derived from goldfish scales [36]. Persson et al. [35] 
have also shown recently that osteoclast activity in the scales 
of the rainbow trout is induced by 17p-estradiol, leading to 
increased scale resorption. Thus, it is possible that scale os-
teoclasts express ER and are targets for the direct actions of 
17P-estradiol during vitellogenesis. The predominant role of 
17P-estradiol in mammalian skeletal tissue is the maintenance 
of bone mass by down-regulation of osteoclastic resorption 
and suppression of bone remodelling [37]. So, clearly, a direct, 
osteoclast-mediated pro-resorptive effect of 17P-estradiol on 
teleost scales would be a contrasting and novel finding. 
The presence of ER mRNA in bone and scale tissues of the 
rainbow trout supports the view that the effects of 17P-estra-
diol on these tissues are directly mediated through ER. Fur-
thermore, the differential effects of 17p-estradiol on calcium 
mobilization in these tissues may reflect differences in the 
sensitivities of the osteoblasts and osteoclasts present to estro-
gen. Indeed, a second ER isoform with a lower affinity for 
17P-estradiol has recently been identified in humans [27]. Pre-
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Fig. 3. Effect of 17p-estradiol on (a) calcium and (b) phosphate contents of bone and scale from rainbow trout. "P<0.01, significant increase 
compared with control; P< 0.001, significant decrease compared with control (Bonferroni (-test). 
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liminary work has shown that it is possible to grow primary 
cells derived from teleost bone and scale in vitro [32] and this 
approach may facilitate mechanistic studies of ER regulation 
in teleost mineralized tissues. 
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